Abstract
Injection of 6-week-old New Zealand (NZB × NZW F1) female mice with parental NZB or NZW spleen cells leads to acceleration of production of antibodies to both single-stranded DNA and thymocytes and to premature reduction in responsiveness to sheep red blood cells (SRBC) and mitogens. Paradoxically, however, NZB × NZW F1 mice injected with parental cells manifest a significantly reduced level of antibodies to native DNA, reduced proteinuria, and prolonged survival. Moreover, New Zealand mice with chronic graft versus host disease develop splenomegaly and significantly elevated serum immunoglobulin concentrations, but no major propensity to develop excessive lymphomas. Finally, the parental splenic cell type responsible for these features is a thy 1.2 bearing radiation-sensitive cell population. The "immunologic storm" produced by injection of parental cells modifies the expression of autoimmunity such that earlier but less pathogenic autoantibodies are produced.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 403-413 |
| Number of pages | 11 |
| Journal | Clinical Immunology and Immunopathology |
| Volume | 10 |
| Issue number | 4 |
| DOIs | |
| State | Published - 1978 |
Fingerprint
ASJC Scopus subject areas
- Immunology
- Immunology and Allergy
- Pathology and Forensic Medicine
Cite this
Graft versus host reaction induced by administration of parental cells : Effect on the autoimmune process of NZB NZW F1 mice. / Gershwin, M. Eric; Steinberg, Alfred D.
In: Clinical Immunology and Immunopathology, Vol. 10, No. 4, 1978, p. 403-413.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Graft versus host reaction induced by administration of parental cells
T2 - Effect on the autoimmune process of NZB NZW F1 mice
AU - Gershwin, M. Eric
AU - Steinberg, Alfred D.
PY - 1978
Y1 - 1978
N2 - Injection of 6-week-old New Zealand (NZB × NZW F1) female mice with parental NZB or NZW spleen cells leads to acceleration of production of antibodies to both single-stranded DNA and thymocytes and to premature reduction in responsiveness to sheep red blood cells (SRBC) and mitogens. Paradoxically, however, NZB × NZW F1 mice injected with parental cells manifest a significantly reduced level of antibodies to native DNA, reduced proteinuria, and prolonged survival. Moreover, New Zealand mice with chronic graft versus host disease develop splenomegaly and significantly elevated serum immunoglobulin concentrations, but no major propensity to develop excessive lymphomas. Finally, the parental splenic cell type responsible for these features is a thy 1.2 bearing radiation-sensitive cell population. The "immunologic storm" produced by injection of parental cells modifies the expression of autoimmunity such that earlier but less pathogenic autoantibodies are produced.
AB - Injection of 6-week-old New Zealand (NZB × NZW F1) female mice with parental NZB or NZW spleen cells leads to acceleration of production of antibodies to both single-stranded DNA and thymocytes and to premature reduction in responsiveness to sheep red blood cells (SRBC) and mitogens. Paradoxically, however, NZB × NZW F1 mice injected with parental cells manifest a significantly reduced level of antibodies to native DNA, reduced proteinuria, and prolonged survival. Moreover, New Zealand mice with chronic graft versus host disease develop splenomegaly and significantly elevated serum immunoglobulin concentrations, but no major propensity to develop excessive lymphomas. Finally, the parental splenic cell type responsible for these features is a thy 1.2 bearing radiation-sensitive cell population. The "immunologic storm" produced by injection of parental cells modifies the expression of autoimmunity such that earlier but less pathogenic autoantibodies are produced.
UR - http://www.scopus.com/inward/record.url?scp=0018122319&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0018122319&partnerID=8YFLogxK
U2 - 10.1016/0090-1229(78)90152-6
DO - 10.1016/0090-1229(78)90152-6
M3 - Article
VL - 10
SP - 403
EP - 413
JO - Clinical Immunology
JF - Clinical Immunology
SN - 1521-6616
IS - 4
ER -